Kezar Life Sciences, Inc.
KZRDelisted May 11, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645666
Kezar Life Sciences, Inc. was delisted on May 11, 2026; its insiders filed their last Form 4 on May 11, 2026; 43 institutions reported holding it in 13F filings for Q1 2026, worth $32.8M in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Kezar Life Sciences, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 123
- −9 vs. Q3 2022
- Shares held
- 57.4M
- −129.5K (−0.2%) vs. Q3 2022
- Total value
- $404.2M
- −$91.3M (−18.4%) vs. Q3 2022
- New holders
- 10
- 55 more added
- Sold out
- 19
- 41 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KZR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 43 | $32.8M |
| Q4 2025 | 43 | $28.1M |
| Q3 2025 | 39 | $16.5M |
| Q2 2025 | 40 | $20.5M |
| Q1 2025 | 41 | $21.1M |
| Q4 2024 | 43 | $28.2M |
| Q3 2024 | 60 | $31.6M |
| Q2 2024 | 81 | $23.6M |
| Q1 2024 | 85 | $40.3M |
| Q4 2023 | 81 | $46.8M |
| Q3 2023 | 82 | $66.0M |
| Q2 2023 | 104 | $139.4M |
| Q1 2023 | 137 | $188.1M |
| Q4 2022 | 123 | $404.2M |
| Q3 2022 | 132 | $495.5M |
| Q2 2022 | 127 | $454.0M |
| Q1 2022 | 123 | $734.1M |
| Q4 2021 | 107 | $674.1M |
| Q3 2021 | 77 | $242.7M |
| Q2 2021 | 75 | $150.1M |
| Q1 2021 | 83 | $158.0M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Kezar Life Sciences, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ikarian Capital, LLC | 629,986 | $4.44M | 1.84% | −98,600−13.5% | Reduced |
| Palo Alto Investors LP | 656,200 | $4.62M | 0.39% | 00.0% | Unchanged |
| Granahan Investment Management Inc | 690,381 | $4.86M | 0.15% | +242,963+54.3% | Added |
| Qiming U.S. Ventures Management, LLC | 828,711 | $5.83M | 7.72% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 976,886 | $6.88M | 0.00% | +35,987+3.8% | Added |
| Northern Trust Corp | 980,109 | $6.90M | 0.00% | +3,578+0.4% | Added |
| JPMorgan Chase & Co | 1,070,866 | $7.54M | 0.00% | +13,118+1.2% | Added |
| Novo Holdings A/S | 1,175,000 | $8.27M | 0.52% | +576,623+96.4% | Added |
| Nuveen Asset Management, LLC | 1,257,288 | $8.85M | 0.00% | −120,009−8.7% | Reduced |
| Sphera Funds Management Ltd. | 1,305,183 | $9.19M | 2.89% | +59,377+4.8% | Added |
| Franklin Resources Inc | 1,365,323 | $9.61M | 0.00% | 00.0% | Unchanged |
| Hood River Capital Management LLC | 1,392,476 | $9.80M | 0.36% | +9,539+0.7% | Added |
| Deerfield Management Company, L.P. (Series C) | 1,430,000 | $10.1M | 0.21% | +1,430,000 | New |
| Prosight Management, LP | 1,754,429 | $12.4M | 6.91% | +426,530+32.1% | Added |
| CHI Advisors LLC | 1,889,451 | $13.3M | 3.54% | +126,658+7.2% | Added |
| Millennium Management LLC | 2,896,495 | $20.4M | 0.02% | −65,773−2.2% | Reduced |
| Vanguard Group Inc | 3,025,983 | $21.3M | 0.00% | +32,776+1.1% | Added |
| Bellevue Group AG | 3,031,000 | $21.3M | 0.28% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 3,504,264 | $24.7M | 1.04% | +228,744+7.0% | Added |
| BlackRock Inc. | 4,230,913 | $29.8M | 0.00% | +125,984+3.1% | Added |
| State Street Corp | 4,253,960 | $29.9M | 0.00% | +716,259+20.2% | Added |
| OrbiMed Advisors LLC | 4,584,322 | $32.3M | 0.62% | +2,812,622+158.8% | Added |
| Avidity Partners Management LP | 6,782,400 | $47.7M | 1.12% | +1,368,000+25.3% | Added |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −2,359,492−100.0% | Sold out |
| HealthCor Management, L.P. | 0 | $0 | 0.00% | −1,607,650−100.0% | Sold out |
| Logos Global Management LP | 0 | $0 | 0.00% | −950,000−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −580,177−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −386,054−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Slow Capital, Inc. | 0 | $0 | 0.00% | −150,663−100.0% | Sold out |
| New York Life Investments Alternatives | 0 | $0 | 0.00% | −93,322−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −42,691−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −26,072−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −19,018−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −18,997−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −18,297−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −12,070−100.0% | Sold out |
| UBS Asset Management Americas Inc | 0 | $0 | 0.00% | −10,017−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −9,700−100.0% | Sold out |
| Robeco Institutional Asset Management B.V. | 0 | $0 | 0.00% | −7,895−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −1,300−100.0% | Sold out |
| JFS Wealth Advisors, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |